PubMedopen access
Effectiveness and safety of brentuximab vedotin-containing regimen versus standard chemotherapy in relapsed or refractory Hodgkin lymphoma: a multicenter cohort study.
humans, hodgkin disease, brentuximab vedotin, female, male, adult
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 362560
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.